Clinical Trials Directory

Trials / Recruiting

RecruitingNCT03151473

Longitudinal Observational Study Of Chinese With NAFLD/NASH

Prospective Cohort Assessing The Prevalence And Progress Of Non-Alcoholic Fatty Liver Disease (NAFLD)/Non-Alcoholic Steatohepatitis (NASH) In Chinese Subjects

Status
Recruiting
Phase
Study type
Observational
Enrollment
20,000 (estimated)
Sponsor
Humanity and Health Research Centre · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

This is a 10-year, longitudinal, observational study of patients with NAFLD/NASH designed to specifically address important clinical questions that remain incompletely answered from registration trials. In addition to the study database, the biospecimen repository will also be included so that translational studies of genomics and biomarkers of response may be performed.

Detailed description

Non-alcoholic fatty liver disease (NAFLD) is an excess accumulation of fat in the liver cells. It is associated with obesity, high blood pressure, high cholesterol, and diabetes. Some people with NAFLD only have excess fat in the liver. However, other people may develop a worse form of NAFLD with liver injury and scarring. This form, called non-alcoholic steatohepatitis (NASH), can lead to liver failure, liver cancer, and death. Not much is known about why some people develop NASH and others do not. This study aims to determine and elucidate, through the cooperative effort of a multidisciplinary and multicenter group of collaborators, the etiology, natural history, diagnosis, treatment, and prevention of NAFLD, and in particular its more severe form of NASH and its complications in Chinese subjects.

Conditions

Timeline

Start date
2017-05-08
Primary completion
2027-05-31
Completion
2027-09-30
First posted
2017-05-12
Last updated
2025-03-24

Locations

1 site across 1 country: Hong Kong

Source: ClinicalTrials.gov record NCT03151473. Inclusion in this directory is not an endorsement.